Nutriband (NASDAQ: NTRB), a company engaged in the development of prescription transdermal pharmaceutical products, has signed a trademark licensing agreement for the use of Bitrex(R) brand denatonium ...

The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...

Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) (as seller), a life science biotechnology company pioneering the use of nature-derived psilocybin ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced that it has entered into a conditional share sale agreement with Psyence Group (CSE: PSYG) (as seller) for the ...

New Delhi [India], September 17: Get ready to experience a groundbreaking advancement in Indian skincare with the arrival of Glutone-Hydra Mouth Melt. This revolutionary product, exclusively featuring ...

A string of troubling headlines have hit the Emeryville Life Science sector in recent months. In July, the SF Business Times ...

Orange Biomed announced today that it plans to showcase its microfluidic-based A1C test at the 2024 Diabetes Technology ...

Psyence Biomedical Ltd. (NASDAQ:PBM) announced a major milestone on Monday with the initiation of the first clinical trial ...

The monoclonal antibody could serve as an emergency treatment for future outbreaks, opening the possibility of broader, more ...

An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains.

Psyence Biomed will issue $500,000 in common shares to Clairvoyant's shareholders upon closing, with additional share-based payments of up to $500,000 tied to pre-specified milestones by December ...